<DOC>
	<DOC>NCT00474253</DOC>
	<brief_summary>The purpose of the trial is to demonstrate a faster recovery from neuromuscular block induced by 1.2 mg/kg ZemuronÂ® after reversal at 3 minutes by 16.0 mg/kg of Org 25969 compared with recovery after a neuromuscular block induced by 1.0 mg/kg succinylcholine.</brief_summary>
	<brief_title>Comparison of Recovery From Rocuronium 1.2 mg/kg Followed By Org 25969 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)</brief_title>
	<detailed_description />
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Succinylcholine</mesh_term>
	<criteria>ASA Class 1 or 2; 18 to 65 years of age (inclusive); Scheduled for elective surgical procedure under general anesthesia requiring a short duration of neuromuscular block with the use of rocuronium or succinylcholine and requiring endotracheal intubation; Scheduled for surgery in supine position; Body mass index (BMI) &lt; 30; Given written informed consent. Subjects with ischemic heart disease or history of myocardial infarction within the last year; Subjects in whom a difficult intubation is expected due to anatomical malformations; Subjects known or suspected to have neuromuscular disorders impairing neuromuscular blockade and/or significant renal dysfunction; Subjects known or suspected to have a (family) history of malignant hyperthermia; Subjects known or suspected to have an allergy to narcotics, muscle relaxants, midazolam, anesthetics or other medications used during surgery; Subjects receiving medication known to interfere with neuromuscular blocking agents such as anticonvulsants, antibiotics and Mg2+; Subjects in whom the use of neostigmine and/or glycopyrrolate may be contraindicated; Female subjects who are pregnant or breastfeeding; Females subjects of childbearing potential not using an acceptable method of birth control [condom or diaphragm with spermicide, vasectomized partner (&gt; 6 months), IUD, abstinence]; Subjects who had already participated in a Org 25969 trial including Protocol 19.4.303;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>